Viral‐mediated gene transfer in the cochlea
dc.contributor.author | Weiss, Melissa A. | |
dc.contributor.author | Frisancho, Juan C. | |
dc.contributor.author | Roessler, Blake J. | |
dc.contributor.author | Raphael, Yehoash | |
dc.date.accessioned | 2020-01-13T15:03:23Z | |
dc.date.available | 2020-01-13T15:03:23Z | |
dc.date.issued | 1997-07 | |
dc.identifier.citation | Weiss, Melissa A.; Frisancho, Juan C.; Roessler, Blake J.; Raphael, Yehoash (1997). "Viral‐mediated gene transfer in the cochlea." International Journal of Developmental Neuroscience 15(4-5): 577-583. | |
dc.identifier.issn | 0736-5748 | |
dc.identifier.issn | 1873-474X | |
dc.identifier.uri | https://hdl.handle.net/2027.42/152513 | |
dc.description.abstract | Gene transfer is an exciting new tool in medical therapy and scientific investigation, but only very recently has it begun to be developed in the auditory system. This paper describes in vivo and ex vivo experiments using an adenoviral vector (Ad. RSVntlacZ), which is a replication‐deficient virus based on a human adenoviral (serotype 5) genomic backbone. The in vivo experiments demonstrate successful gene transfer into multiple types of cochlear cells. We observed a relatively efficient transduction, several weeks of sustained transgene expression and an absence of major lethal cytotoxicity in spiral ganglion and epithelial cells of the cochlea in adult animals. The ex vivo experiments were performed using fibroblasts transduced in vitro with Ad. RSVntlacZ. Two weeks after inoculation of the fibroblasts into the perilymph, we observed transplanted fibroblasts, which were adherent to the lining of the perilymphatic spaces, and were expressing the lacZ transgene. We speculate that, as the genetic basis of degenerative cochlear diseases is characterized on a mutational level, transgene expression will allow us to test hypotheses regarding the effects of specific genes on cochlear cell biology. Gene transfer will not only increase our understanding of the pathophysiology of hearing loss, but also may provide gene therapy for disease. | |
dc.publisher | Academic press | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | adenoviral vectors | |
dc.subject.other | cochlea | |
dc.subject.other | adenovirus | |
dc.subject.other | gene therapy | |
dc.subject.other | guinea pig | |
dc.title | Viral‐mediated gene transfer in the cochlea | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Neurology and Neurosciences | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/152513/1/jdns0736574896001128.pdf | |
dc.identifier.doi | 10.1016/S0736-5748(96)00112-8 | |
dc.identifier.source | International Journal of Developmental Neuroscience | |
dc.identifier.citedreference | M.A. Rosenfeld, W. Siegfried, K. Yoshimura, K. Yoneyama, M. Fukayama, L.E. Stier, P.K. Paakko, P. Gilardi, L.D. Stratford‐Perricaudet, M. Perricaudet, S. Jallet, A. Pavirani, J.‐P. Lecocq, R.G. Crystal. Adenovirusmediated transfer of a recombinant alpha 1‐antitrypsin gene to the lung epithelium in vivo. Science. 252: 1991; 431 – 434 | |
dc.identifier.citedreference | S. Dazert, A. Battaglia, A.F. Ryan. Transfection of neonatal rat cochlear cells in vitro with an adenovirus vector. Intl J. Dev. Neurosci. 15: 1997; 595 – 600 | |
dc.identifier.citedreference | S.E. Doran, B.J. Roessler, J.W. Hartman, J.T. Hoff, D.S. Shewach, B.L. Davidson. Adenovirus‐mediated in vivo gene transfer into the central nervous system of a nonhuman primate (resident award paper). Clin. Neurosurg. 41: 1994; 242 – 257 | |
dc.identifier.citedreference | D.J. Fink, L.R. Steinberg, P.C. Weber, M. Mata, W.F. Goins, J.C. Glorioso. In vivo expression of betagalactosidase in hippocampal neurons by HSV‐mediated gene transfer. Hum. Gene Ther. 3: 1992; 11 – 19 | |
dc.identifier.citedreference | J.C. Glorioso, W.F. Coins, C.A. Meaney, D.J. Fink, N.A. DeLuca. Gene transfer to brain using herpes simplex virus vectors. Ann. Neurol. 35: 1994; S28 – S34, Suppl | |
dc.identifier.citedreference | R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, T. Finkel. Efficient and selective adenovirusmediated gene transfer into vascular neointima. Circulation. 88: 1993; 2838 – 2848 | |
dc.identifier.citedreference | H.A. Jaffe, C. Danel, G. Longenecker, M. Metzger, Y. Setoguchi, M.A. Rosenfeld. Adenovirus‐mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1: 1992; 372 – 378 | |
dc.identifier.citedreference | R.W. Jyung, J.M. Miller, S.C. Cannon. Evaluation of eighth nerve integrity by the electrically evoked middle latency response. Otolaryngol. Head Neck Surg. 101: 1989; 670 – 682 | |
dc.identifier.citedreference | M.G. Kaplitt, P. Leone, R.J. Samulski, X. Xiao, D.W. Pfaff, K.L. O’Malley, M.J. During. Long‐term gene expression and phenotypic correction using adeno‐associated virus vectors in the mammalian brain. Nat. Genet. 8: 1994; 148 – 154 | |
dc.identifier.citedreference | M.G. Kaplitt, A.D. Loewy. Viral Vectors: Gene Therapy and Neuroscience Applications. 1995; Academic Press: San Diego, CA | |
dc.identifier.citedreference | R.J. Korst, B. Bewig, R.G. Crystal. In vitro and in vivo transfer and expression of human surfactant SP‐Aand SP‐B‐associated protein cDNAs mediated by replication‐deficient, recombinant adenoviral vectors. Hum. Gene Ther. 6: 1995; 277 – 287 | |
dc.identifier.citedreference | A.K. Lalwani, B.J. Walsh, P.G. Reilly, N. Muzyczka, A.N. Mhatre. Development of in vivo gene therapy for hearing disorders: introduction of adeno‐associated virus into the cochlea of the guinea pig. Gene Ther. 3: 1996; 588 – 592 | |
dc.identifier.citedreference | G. Le Gal La Salle, J.J. Robert, S. Berrard, V. Ridoux, L.D. Stratford‐Perricaudet, M. Perricaudet, J. Mallet. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259: 1993; 988 – 990 | |
dc.identifier.citedreference | R.D. McCoy, B.L. Davidson, B.J. Roessler, G.B. Huffnagle, R.H. Simon. Expression of human interleukin1 receptor antagonist in mouse lungs using a recombinant adenovirus: effects on vector‐induced inflammation. Gene Ther. 2: 1995; 437 – 444 | |
dc.identifier.citedreference | D.G. Miller, A.D. Miller. Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera. J. Virol. 67: 1993; 5346 – 5352 | |
dc.identifier.citedreference | Y. Raphael, J.C. Frisancho, B.J. Roessler. Adenoviral‐mediated gene transfer into guinea pig cochlear cells in vivo. Neurosci. Lett. 207: 1996; 137 – 141 | |
dc.identifier.citedreference | B.J. Roessler, J.W. Hartman, K.D. Vallace, J.M. Latta, S.L. Janich, B.L. Davidson. Inhibition of interleukin‐l‐induced effects in synoviocytes transduced with the human IL‐1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6: 1995; 307 – 316 | |
dc.identifier.citedreference | M.A. Rosenfeld, K. Yoshimura, B.C. Trapnell, K. Yoneyama, E.R. Rosenthai, W. Dalemans, M. Fukayama, J. Bargon, L.E. Stier, L. Stratford‐Perricaudet, M. Perricaudet, W.B. Guggino, A. Pavirani, J.‐P. Lecocq, R.G. Crystal. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 68: 1992; 143 – 155 | |
dc.identifier.citedreference | R.A. Schindler, H.B. Gladstone, N. Scott, G.T. Hradek, H. Williams, S.B. Shah. Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. Am. J. Otol. 16: 1995; 304 – 309 | |
dc.identifier.citedreference | S.B. Shah, H.B. Gladstone, H. Williams, G.T. Hradek, R.A. Schindler. An extended study: protective effects of nerve growth factor in neomycin‐induced auditory neural degeneration. Am. J. Otol. 16: 1995; 310 – 314 | |
dc.identifier.citedreference | T. Shenk. Viral Vectors: Gene Therapy and Neuroscience Applications M.G. Kaplitt, A.D. Loewy 1995; Academic Press: San Diego, CA; 43 – 53 | |
dc.identifier.citedreference | M. Webster, D.B. Webster. Spiral ganglion neuron loss following organ of Corti loss: a quantitative study. Brain Res. 212: 1981; 17 – 30 | |
dc.identifier.citedreference | M.J. Welsh, A.E. Smith, J. Zabner, D.P. Rich, S.M. Graham, R.J. Gregory, B.M. Pratt, R.A. Moscicki. Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5: 1994; 209 – 219 | |
dc.identifier.citedreference | B.A. West, R.E. Brummett, D.L. Himes. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch. Otolaryngol. 98: 1973; 32 – 37 | |
dc.identifier.citedreference | R. Bannerji. Viral Vectors: Gene Therapy and Neuroscience Applications M.G. Kaplitt, A.D. Loewy 1995; Academic press: San Diego, CA; 75 – 88 | |
dc.identifier.citedreference | S.L. Brody, R.G. Crystal. Adenovirus‐mediated in vivo gene transfer. Ann. NY Acad. Sci. 716: 1994; 90 – 101 | |
dc.identifier.citedreference | J.N. Brown, J.M. Miller, R.A. Altschuler, A.L. Nuttall. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hearing Res. 70: 1993; 167 – 172 | |
dc.identifier.citedreference | R.G. Crystal, N.G. McElvaney, M.A. Rosenfeld, C.S. Chu, A. Mastrangeli, J.G. Hay, S.L. Brody, H.A. Jaffe, N.T. Eissa, C. Danel. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8: 1994; 42 – 51 | |
dc.identifier.citedreference | B.L. Davidson, E.D. Allen, K.F. Kozarsky, J.M. Wilson, B.J. Roessler. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat. Genet. 3: 1993; 219 – 223 | |
dc.identifier.citedreference | B.L. Davidson, S.E. Doran, D.S. Shewach, J.M. Latta, J.W. Hartman, B.J. Roessler. Expression of Escherichia coli beta‐galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral‐mediated gene transfer. Expl Neurol. 125: 1994; 258 – 267 | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.